Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

September 3, 2019

Primary Completion Date

February 21, 2020

Study Completion Date

February 21, 2020

Conditions
Schistosomiasis
Interventions
DRUG

Praziquantel 600Mg Oral Tablet x 5

Five doses of Praziquantel 40 mg/kg

DRUG

Praziquantel 600Mg Oral Tablet x 1

Single dose of Praziquantel 40 mg/kg

Trial Locations (1)

203

K'Olo Vanona, Ambanja

All Listed Sponsors
collaborator

Charite University, Berlin, Germany

OTHER

collaborator

Leiden University Medical Center

OTHER

collaborator

Nagasaki University

OTHER

collaborator

Umeå University

OTHER

collaborator

Merck Serono International SA

INDUSTRY

collaborator

Ministry of Health, Madagascar

OTHER_GOV

lead

Regionshospital Nordjylland

OTHER_GOV

NCT04115072 - Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study | Biotech Hunter | Biotech Hunter